12/4
10:20 pm
eprx
Analysts See More Than 77% Upside for Eupraxia Pharmaceuticals (EPRX), Here's Why [Yahoo! Finance]
Low
Report
Analysts See More Than 77% Upside for Eupraxia Pharmaceuticals (EPRX), Here's Why [Yahoo! Finance]
11/23
02:11 am
eprx
Eupraxia Pharmaceuticals (NASDAQ:EPRX) was downgraded by analysts at
Wal
Low
Report
Eupraxia Pharmaceuticals (NASDAQ:EPRX) was downgraded by analysts at
Wal
11/17
05:56 am
eprx
Individual investors account for 43% of Eupraxia Pharmaceuticals Inc.'s (TSE:EPRX) ownership, while institutions account for 26% [Yahoo! Finance]
Low
Report
Individual investors account for 43% of Eupraxia Pharmaceuticals Inc.'s (TSE:EPRX) ownership, while institutions account for 26% [Yahoo! Finance]
11/15
01:42 am
eprx
Eupraxia Pharmaceuticals (NASDAQ:EPRX) was upgraded by analysts at
Wall
Low
Report
Eupraxia Pharmaceuticals (NASDAQ:EPRX) was upgraded by analysts at
Wall
11/4
05:28 pm
eprx
Eupraxia Pharmaceuticals Reports Third Quarter 2025 Financial Results [Canadian Business Journal (Canada)]
Medium
Report
Eupraxia Pharmaceuticals Reports Third Quarter 2025 Financial Results [Canadian Business Journal (Canada)]
11/4
04:39 pm
eprx
Eupraxia Pharmaceuticals Reports Third Quarter 2025 Financial Results
Medium
Report
Eupraxia Pharmaceuticals Reports Third Quarter 2025 Financial Results
10/30
07:50 am
eprx
Eupraxia Pharmaceuticals (NASDAQ:EPRX) was upgraded by analysts at Leede Financial to a "strong-buy" rating.
Low
Report
Eupraxia Pharmaceuticals (NASDAQ:EPRX) was upgraded by analysts at Leede Financial to a "strong-buy" rating.
10/14
08:11 pm
eprx
Wall Street Analysts Believe Eupraxia Pharmaceuticals Inc. (EPRX) Could Rally 85.12%: Here's is How to Trade [Yahoo! Finance]
Medium
Report
Wall Street Analysts Believe Eupraxia Pharmaceuticals Inc. (EPRX) Could Rally 85.12%: Here's is How to Trade [Yahoo! Finance]
10/3
03:35 pm
eprx
Eupraxia Pharmaceuticals (NASDAQ:EPRX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Eupraxia Pharmaceuticals (NASDAQ:EPRX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
9/29
05:25 pm
eprx
Eupraxia Pharmaceuticals Announces Positive Data from Highest-Dose Cohort in the Ongoing RESOLVE Trial in Eosinophilic Esophagitis, and Plans for Expansion of EP-104GI Development Programs [Yahoo! Finance]
High
Report
Eupraxia Pharmaceuticals Announces Positive Data from Highest-Dose Cohort in the Ongoing RESOLVE Trial in Eosinophilic Esophagitis, and Plans for Expansion of EP-104GI Development Programs [Yahoo! Finance]
9/29
05:00 pm
eprx
Eupraxia Pharmaceuticals Announces Positive Data from Highest-Dose Cohort in the Ongoing RESOLVE Trial in Eosinophilic Esophagitis, and Plans for Expansion of EP-104GI Development Programs
Low
Report
Eupraxia Pharmaceuticals Announces Positive Data from Highest-Dose Cohort in the Ongoing RESOLVE Trial in Eosinophilic Esophagitis, and Plans for Expansion of EP-104GI Development Programs
9/28
09:25 am
eprx
Independent Director of Eupraxia Pharmaceuticals Picks Up 13% More Stock [Yahoo! Finance]
Low
Report
Independent Director of Eupraxia Pharmaceuticals Picks Up 13% More Stock [Yahoo! Finance]
9/25
02:15 am
eprx
Peterson Capital Hosts Canada Growth Conference in Ireland [Yahoo! Finance]
Medium
Report
Peterson Capital Hosts Canada Growth Conference in Ireland [Yahoo! Finance]
9/25
02:00 am
eprx
Peterson Capital Hosts Canada Growth Conference in Ireland
Medium
Report
Peterson Capital Hosts Canada Growth Conference in Ireland
9/24
08:54 am
eprx
Eupraxia Pharmaceuticals Announces Closing of US$80.5 Million Public Offering Including Full Exercise of Underwriter Option
Medium
Report
Eupraxia Pharmaceuticals Announces Closing of US$80.5 Million Public Offering Including Full Exercise of Underwriter Option
9/22
10:42 pm
eprx
Eupraxia Pharmaceuticals Announces Pricing of US$70 Million Public Offering of Common Shares
Medium
Report
Eupraxia Pharmaceuticals Announces Pricing of US$70 Million Public Offering of Common Shares
9/22
04:24 pm
eprx
Eupraxia Pharmaceuticals Announces Proposed Public Offering of Common Shares [Yahoo! Finance]
High
Report
Eupraxia Pharmaceuticals Announces Proposed Public Offering of Common Shares [Yahoo! Finance]
9/22
04:01 pm
eprx
Eupraxia Pharmaceuticals Announces Proposed Public Offering of Common Shares
Medium
Report
Eupraxia Pharmaceuticals Announces Proposed Public Offering of Common Shares